Shareholder Information

Shares Issued

As at 7 February 2020, the number of shares in issue was 397,253,969.

Significant Shareholders

As at 7 February 2020

Shareholder Number Ordinary
Shares %
Craig Auringer 31,407,913 7.91
Samantha Bauer 17,996,487 4.53
Ron Valk 17,131,193 4.31
Mark Hawtin 13,268,570 3.34

Director Shareholdings

As at 7 February 2020

Director Number Ordinary
Shares %
Alexis Sandler 75,090,685 18.90
Dr Vladislav Sandler 41,544,677 10.46
Peter Redmond 5,596,270 1.41

Shares Not In Public Hands

Insofar as it is aware, as at 7 February 2020, 56.32% of the Company’s securities were not in public hands.

UK City Code On Takeovers And Mergers

The Company is subject to the provisions of the City Code on Takeovers and Mergers.

Shareholder Circulars

28 May 2019 Notice of AGM to held on 28 June 2019

Other Exchanges And Trading Platforms

Hemogenyx Pharmaceuticals plc has not applied or agreed to have any of it securities admitted or traded on any other exchanges or trading platforms.